BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26923404)

  • 1. Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy.
    Ramirez LM; Goukasian N; Porat S; Hwang KS; Eastman JA; Hurtz S; Wang B; Vang N; Sears R; Klein E; Coppola G; Apostolova LG
    Neurobiol Aging; 2016 Mar; 39():82-9. PubMed ID: 26923404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease.
    Chung SJ; Kim MJ; Kim YJ; Kim J; You S; Jang EH; Kim SY; Lee JH
    J Neurol Sci; 2014 Apr; 339(1-2):91-6. PubMed ID: 24530172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer's Disease.
    Almeida JFF; Dos Santos LR; Trancozo M; de Paula F
    J Mol Neurosci; 2018 Mar; 64(3):471-477. PubMed ID: 29504051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Vázquez-Higuera JL; Mateo I; Pozueta A; Berciano J; Cervantes S; Alcolea D; Martínez-Lage P; Clarimón J; Lleó A; Pastor P; Combarros O
    J Neural Transm (Vienna); 2013 May; 120(5):807-12. PubMed ID: 23180304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.
    Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures.
    Ma J; Zhang W; Tan L; Wang HF; Wan Y; Sun FR; Tan CC; Yu JT; Tan L; Alzheimer's Disease Neuroimaging Initiative
    Oncotarget; 2016 Sep; 7(37):58779-58788. PubMed ID: 27244883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
    Hollingworth P; Harold D; Sims R; Gerrish A; Lambert JC; Carrasquillo MM; Abraham R; Hamshere ML; Pahwa JS; Moskvina V; Dowzell K; Jones N; Stretton A; Thomas C; Richards A; Ivanov D; Widdowson C; Chapman J; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Holmes C; Mann D; Smith AD; Beaumont H; Warden D; Wilcock G; Love S; Kehoe PG; Hooper NM; Vardy ER; Hardy J; Mead S; Fox NC; Rossor M; Collinge J; Maier W; Jessen F; Rüther E; Schürmann B; Heun R; Kölsch H; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Gallacher J; Hüll M; Rujescu D; Giegling I; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Sleegers K; Bettens K; Engelborghs S; De Deyn PP; Van Broeckhoven C; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Pankratz VS; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Dickson DW; Graff-Radford NR; Petersen RC; ; van Duijn CM; Breteler MM; Ikram MA; DeStefano AL; Fitzpatrick AL; Lopez O; Launer LJ; Seshadri S; ; Berr C; Campion D; Epelbaum J; Dartigues JF; Tzourio C; Alpérovitch A; Lathrop M; ; Feulner TM; Friedrich P; Riehle C; Krawczak M; Schreiber S; Mayhaus M; Nicolhaus S; Wagenpfeil S; Steinberg S; Stefansson H; Stefansson K; Snaedal J; Björnsson S; Jonsson PV; Chouraki V; Genier-Boley B; Hiltunen M; Soininen H; Combarros O; Zelenika D; Delepine M; Bullido MJ; Pasquier F; Mateo I; Frank-Garcia A; Porcellini E; Hanon O; Coto E; Alvarez V; Bosco P; Siciliano G; Mancuso M; Panza F; Solfrizzi V; Nacmias B; Sorbi S; Bossù P; Piccardi P; Arosio B; Annoni G; Seripa D; Pilotto A; Scarpini E; Galimberti D; Brice A; Hannequin D; Licastro F; Jones L; Holmans PA; Jonsson T; Riemenschneider M; Morgan K; Younkin SG; Owen MJ; O'Donovan M; Amouyel P; Williams J
    Nat Genet; 2011 May; 43(5):429-35. PubMed ID: 21460840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.
    Carrasquillo MM; Crook JE; Pedraza O; Thomas CS; Pankratz VS; Allen M; Nguyen T; Malphrus KG; Ma L; Bisceglio GD; Roberts RO; Lucas JA; Smith GE; Ivnik RJ; Machulda MM; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
    Neurobiol Aging; 2015 Jan; 36(1):60-7. PubMed ID: 25189118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease.
    Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F
    J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Cuyvers E; De Roeck A; Van den Bossche T; Van Cauwenberghe C; Bettens K; Vermeulen S; Mattheijssens M; Peeters K; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Lancet Neurol; 2015 Aug; 14(8):814-822. PubMed ID: 26141617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood.
    Proitsi P; Lee SH; Lunnon K; Keohane A; Powell J; Troakes C; Al-Sarraj S; Furney S; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Hodges A;
    Neurobiol Aging; 2014 Feb; 35(2):279-90. PubMed ID: 24064185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.
    De Roeck A; Van Broeckhoven C; Sleegers K
    Acta Neuropathol; 2019 Aug; 138(2):201-220. PubMed ID: 30903345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease.
    Yamazaki K; Yoshino Y; Mori T; Yoshida T; Ozaki Y; Sao T; Mori Y; Ochi S; Iga JI; Ueno SI
    J Alzheimers Dis; 2017; 57(1):171-181. PubMed ID: 28222527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.
    Karch CM; Jeng AT; Nowotny P; Cady J; Cruchaga C; Goate AM
    PLoS One; 2012; 7(11):e50976. PubMed ID: 23226438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.
    Schott JM; Crutch SJ; Carrasquillo MM; Uphill J; Shakespeare TJ; Ryan NS; Yong KX; Lehmann M; Ertekin-Taner N; Graff-Radford NR; Boeve BF; Murray ME; Khan QU; Petersen RC; Dickson DW; Knopman DS; Rabinovici GD; Miller BL; González AS; Gil-Néciga E; Snowden JS; Harris J; Pickering-Brown SM; Louwersheimer E; van der Flier WM; Scheltens P; Pijnenburg YA; Galasko D; Sarazin M; Dubois B; Magnin E; Galimberti D; Scarpini E; Cappa SF; Hodges JR; Halliday GM; Bartley L; Carrillo MC; Bras JT; Hardy J; Rossor MN; Collinge J; Fox NC; Mead S
    Alzheimers Dement; 2016 Aug; 12(8):862-71. PubMed ID: 26993346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
    Jack CR; Wiste HJ; Weigand SD; Knopman DS; Mielke MM; Vemuri P; Lowe V; Senjem ML; Gunter JL; Reyes D; Machulda MM; Roberts R; Petersen RC
    Brain; 2015 Dec; 138(Pt 12):3747-59. PubMed ID: 26428666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD.
    Carrasquillo MM; Khan Qu; Murray ME; Krishnan S; Aakre J; Pankratz VS; Nguyen T; Ma L; Bisceglio G; Petersen RC; Younkin SG; Dickson DW; Boeve BF; Graff-Radford NR; Ertekin-Taner N
    Neurology; 2014 Apr; 82(16):1455-62. PubMed ID: 24670887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.
    Apostolova LG; Hwang KS; Medina LD; Green AE; Braskie MN; Dutton RA; Lai J; Geschwind DH; Cummings JL; Thompson PM; Ringman JM
    Dement Geriatr Cogn Disord; 2011; 32(2):118-25. PubMed ID: 21952501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
    Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.